Peter Haytaian, who serves as executive vice president and president of the Carelon services division at Elevance Health Inc. (NYSE:ELV), is planning to leave the company. Haytaian oversees Carelon, the business unit within Elevance that encompasses pharmacy benefits and a range of other services beyond conventional health insurance coverage.
Carelon has been described within the company as a rapidly growing component of Elevance's operations, expanding the firm's footprint in services that complement its insurance business. Haytaian's leadership of that division positioned him as a prominent executive within the organization.
Within internal and external circles, Haytaian had been considered a possible candidate to take over as chief executive from Gail Boudreaux. Boudreaux has been the company's chief executive officer since 2017, and discussions around succession have included Haytaian because of his role overseeing Carelon.
At present, Elevance Health has not disclosed any timeline for Haytaian's departure. The company also has not issued a public comment regarding his intentions to leave or on any related transition planning.
Carelon represents an important business segment for Elevance Health, offering services that extend beyond the traditional scope of health insurance. Its portfolio includes pharmacy benefits as well as other service offerings that contribute to the company's broader commercial operations and strategic positioning in health services.
Details remain limited to the information currently available. There has been no formal announcement from Elevance Health outlining a replacement plan for the Carelon leadership or specifying when Haytaian's departure will occur.
Summary
Peter Haytaian, president of Carelon services at Elevance Health, is planning to leave the company. Carelon provides pharmacy benefits and additional services and has been growing rapidly. Haytaian was viewed as a potential successor to CEO Gail Boudreaux, who has led the company since 2017. Elevance has not announced a timeline or provided public comment on the executive's plans.